AIMS: To develop and describe an objective classification system for the spatial patterns of visual field loss found in glaucoma. METHODS: The 560 Humphrey visual field analyser (program 24-2) records were used to train an artificial neural network (ANN). The type of network used, a Kohonen self organising feature map (SOM), was configured to organise the visual field defects into 25 classes of superior visual field loss and 25 classes of inferior visual field loss. Each group of 25 classes was arranged in a 5 by 5 map. RESULTS: The SOM successfully classified the defects on the basis of the patterns of loss. The maps show a continuum of change as one moves across them with early loss at one corner and advanced loss at the opposite corner. CONCLUSIONS: ANNs can classify visual field data on the basis of the pattern of loss. Once trained the ANN can be used to classify longitudinal visual field data which may prove valuable in monitoring visual field loss.
AIMS: To develop and describe an objective classification system for the spatial patterns of visual field loss found in glaucoma. METHODS: The 560 Humphrey visual field analyser (program 24-2) records were used to train an artificial neural network (ANN). The type of network used, a Kohonen self organising feature map (SOM), was configured to organise the visual field defects into 25 classes of superior visual field loss and 25 classes of inferior visual field loss. Each group of 25 classes was arranged in a 5 by 5 map. RESULTS: The SOM successfully classified the defects on the basis of the patterns of loss. The maps show a continuum of change as one moves across them with early loss at one corner and advanced loss at the opposite corner. CONCLUSIONS: ANNs can classify visual field data on the basis of the pattern of loss. Once trained the ANN can be used to classify longitudinal visual field data which may prove valuable in monitoring visual field loss.
Authors: M H Goldbaum; P A Sample; H White; B Côlt; P Raphaelian; R D Fechtner; R N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 1994-08 Impact factor: 4.799
Authors: Michael H Goldbaum; Pamela A Sample; Zuohua Zhang; Kwokleung Chan; Jiucang Hao; Te-Won Lee; Catherine Boden; Christopher Bowd; Rupert Bourne; Linda Zangwill; Terrence Sejnowski; David Spinak; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2005-10 Impact factor: 4.799
Authors: Christopher Bowd; Intae Lee; Michael H Goldbaum; Madhusudhanan Balasubramanian; Felipe A Medeiros; Linda M Zangwill; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2012-04-30 Impact factor: 4.799
Authors: Tobias Elze; Louis R Pasquale; Lucy Q Shen; Teresa C Chen; Janey L Wiggs; Peter J Bex Journal: J R Soc Interface Date: 2015-02-06 Impact factor: 4.118
Authors: Catherine Boden; Kwokleung Chan; Pamela A Sample; Jiucang Hao; Te-Wan Lee; Linda M Zangwill; Robert N Weinreb; Michael H Goldbaum Journal: Invest Ophthalmol Vis Sci Date: 2007-12 Impact factor: 4.799
Authors: Pamela A Sample; Catherine Boden; Zuohua Zhang; John Pascual; Te-Won Lee; Linda M Zangwill; Robert N Weinreb; Jonathan G Crowston; Esther M Hoffmann; Felipe A Medeiros; Terrence Sejnowski; Michael Goldbaum Journal: Invest Ophthalmol Vis Sci Date: 2005-10 Impact factor: 4.799
Authors: Steven E Feldon; Lori Levin; Roberta W Scherer; Anthony Arnold; Sophia M Chung; Lenworth N Johnson; Gregory Kosmorsky; Steven A Newman; Joanne Katz; Patricia Langenberg; P David Wilson; Shalom E Kelman; Kay Dickersin Journal: BMC Ophthalmol Date: 2006-11-20 Impact factor: 2.209